Literature DB >> 17577135

Stem cell mechanisms and paracrine effects: potential in cardiac surgery.

Paul R Crisostomo1, Meijing Wang, Troy A Markel, Tim Lahm, Aaron M Abarbanell, Jeremy L Herrmann, Daniel R Meldrum.   

Abstract

Heart disease remains the leading cause of death in the industrialized world. Stem cell therapy is a promising treatment modality for injured cardiac tissue. A novel mechanism for this cardioprotection may include paracrine actions. Cardiac surgery represents the unique situation where preischemia and postischemia treatment modalities exist that may use stem cell paracrine protection. This review (1) recalls the history of stem cells in cardiac disease and the unraveling of its mechanistic basis for protection, (2) outlines the pathways for stem cell-mediated paracrine protection, (3) highlights the signaling factors expressed, (4) explores the potential of using stem cells clinically in cardiac surgery, and (5) summarizes all human stem cell studies in cardiac disease to date.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577135     DOI: 10.1097/shk.0b013e318058a817

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  23 in total

Review 1.  The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease.

Authors:  Brent R Weil; Mariuxi C Manukyan; Jeremy L Herrmann; Aaron M Abarbanell; Jeffrey A Poynter; Yue Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2010-08-06       Impact factor: 2.192

2.  Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions.

Authors:  Paul R Crisostomo; Aaron M Abarbanell; Meijing Wang; Tim Lahm; Yue Wang; Daniel R Meldrum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

Review 3.  Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy.

Authors:  Yingli Fu; Dara L Kraitchman
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 4.  Gender dimorphisms in progenitor and stem cell function in cardiovascular disease.

Authors:  Jeremy L Herrmann; Aaron M Abarbanell; Brent R Weil; Mariuxi C Manukyan; Jeffrey A Poynter; Yue Wang; Arthur C Coffey; Daniel R Meldrum
Journal:  J Cardiovasc Transl Res       Date:  2010-04       Impact factor: 4.132

5.  Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function.

Authors:  Bixi Jian; Shaolong Yang; Dongquan Chen; Irshad Chaudry; Raghavan Raju
Journal:  Biochim Biophys Acta       Date:  2011-04-30

6.  TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.

Authors:  Megan L Kelly; Meijing Wang; Paul R Crisostomo; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Daniel R Meldrum
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

Review 7.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

8.  High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation.

Authors:  Brent R Weil; Aaron M Abarbanell; Jeremy L Herrmann; Yue Wang; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-22       Impact factor: 3.619

9.  TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms.

Authors:  Yue Wang; Paul R Crisostomo; Meijing Wang; Troy A Markel; Nathan M Novotny; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

10.  Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia.

Authors:  Graham S Erwin; Paul R Crisostomo; Yue Wang; Meijing Wang; Troy A Markel; Mike Guzman; Ian C Sando; Rahul Sharma; Daniel R Meldrum
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.